25th International Workshop on Long-term Complications of HIV and SARS-CoV-2

第 25 届艾滋病毒和 SARS-CoV-2 长期并发症国际研讨会

• 批准号: 10828053
• 负责人: TODD T BROWN
• 金额: $ 6.83万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-16 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10828053
• 关键词: 2019-nCoV; Acute; Adverse effects; Affect; Age; COVID-19; COVID-19 pandemic; Cardiovascular Diseases; Cause of Death; Chronic; Chronic Disease; Clinical; Collaborations; Communities; Discipline; Disease; Educational workshop; Etiology; Europe; Feedback; Fostering; Funding Opportunities; Goals; Grant; HIV; HIV Infections; Home; Inflammation; International; Learning; Liver diseases; Long COVID; Longevity; Malignant Neoplasms; Maryland; NIH Office of AIDS Research; Names; National Institute of Allergy and Infectious Disease; Oral; Pathogenesis; Pathogenicity; Patients; Persons; Physiological; Play; Post-Acute Sequelae of SARS-CoV-2 Infection; Research; Research Personnel; Resources; Risk Factors; Role; Schedule; Scholarship; Science; Symptoms; Syndrome; System; Training Programs; Translational Research; Travel; United States National Institutes of Health; Work; Writing; acute infection; antiretroviral therapy; career development; clinical practice; comorbidity; coronavirus disease; design; disability; healthspan; improved; innovation; interest; low and middle-income countries; meetings; multidisciplinary; peer; persistent symptom; posters; programs; skills; success; virtual

With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including in low- and middle- income countries (LMIC). Large meetings are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. In addition, there is a need for a forum for scientific exchange regarding post-acute sequelae of COVID-19 (PASC), a poorly understood syndrome which may share pathogenic features with HIV comorbidities and, as a result, has attracted the interest of many HIV Comorbidity researchers. Our workshop, now in its 25th year and renamed the International Workshop on Long-term Complications of HIV and SARS-CoV-2, provides <200 international delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity and PASC research in a one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. A highly interactive PASC roundtable, with 2 mini-talks, highlights critical and emerging issues in the pathogenesis and management of PASC. Abstract presentations including 24 15-minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 25th Workshop (December 14th/15th at the NIH in Rockville, MD) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to provide a continued and expanded forum for discussion and dissemination of the latest research findings regarding PASC, 3) to support early-stage HIV Comorbidity and PASC investigators with a highly innovative day-long Career Development Studio prior to the Workshop (December 13th). By providing a “scientific home” to HIV Comorbidity and PASC investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and PASC and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH and those with long COVID.

随着抗逆转录病毒疗法（ART）的成功，合并症现在是主要原因 全球艾滋病毒感染者的死亡和残疾，包括低和中间 收入国家（LMIC）。大型会议是有关科学交流的重要场所 HIV合并症研究的最新进展，但更小，更亲密的格式 强调讨论和网络对于HIV合并症的职业发展至关重要 调查人员。此外，需要一个关于急性后科学交流的论坛 COVID-19（PASC）的后遗症，这是一种综合征，可能具有致病性的综合征。 HIV合并症的功能，因此吸引了许多HIV的兴趣 合并症研究人员。我们的研讨会，现在已有25年，并更名为国际 HIV和SARS-COV-2长期并发症的研讨会提供<200国际 有机会聚集在一起讨论最新发现和争议的代表 艾滋病毒合并症和PASC研究以一室，两天的格式。全体扬声器是 来自艾滋病毒研究以外的著名专家或具有特定专业知识的艾滋病毒研究人员 合并症。一个高度交互式的PASC圆桌会议，带有2个迷你讲话，突出显示至关重要， PASC的发病机理和管理中的新兴问题。抽象演示 包括24次15分钟的会谈和海报会议为研究人员提供了足够的机会 呈现并获得有关他们最新工作的反馈。使用此R13，我们建议增强25号 讲习班（12月14日/15日在马里兰州罗克维尔的NIH举行），其目的是：1） LMIC最新的HIV合并症研究论坛，通过向LMIC提供旅行科学 调查人员支持国际公认的非传染性疾病专家 LMIC作为全体发言人，并与国际培训计划联络，2） 继续和扩大论坛，以讨论和传播最新的研究结果 关于PASC，3）支持早期的HIV合并症和PASC调查员， 研讨会之前（12月13日）之前的创新一天的职业发展工作室。经过 为来自世界各地的艾滋病毒合并症和PASC调查人员提供“科学家”， 我们希望催化未来的HIV合并症研究工作和PASC，并促进 将研究发现转化为临床策略，可以改善寿命和 PLWH的HealthSpan和较长的covid的人。